(Q37709456)

22 August 2017

The implication of FLT3 amplification for FLT targeted therapeutics in solid tumors (English)

1 reference

22 August 2017

6

Kyoung-Mee Kim

1 reference

22 August 2017

Sung Hee Lim

1

1 reference

22 August 2017

Sun-Young Kim

2

1 reference

22 August 2017

Kyung Kim

3

1 reference

22 August 2017

Hyojin Jang

4

1 reference

22 August 2017

Soomin Ahn

5

1 reference

22 August 2017

Nayoung K D Kim

7

1 reference

22 August 2017

Woongyang Park

8

1 reference

22 August 2017

Su Jin Lee

9

1 reference

22 August 2017

Seung Tae Kim

10

1 reference

22 August 2017

Se Hoon Park

11

1 reference

22 August 2017

Joon Oh Park

12

1 reference

22 August 2017

Young Suk Park

13

1 reference

22 August 2017

Se-Hoon Lee

14

1 reference

22 August 2017

Ho Yeong Lim

15

1 reference

22 August 2017

Keunchil Park

16

1 reference

22 August 2017

Won Ki Kang

17

1 reference

22 August 2017

Jeeyun Lee

18

1 reference

22 August 2017

language of work or name

English

0 references

publication date

29 November 2016

1 reference

22 August 2017

1 reference

22 August 2017

8

1 reference

22 August 2017

2

1 reference

22 August 2017

3237-3245

1 reference

NTRK1 rearrangement in colorectal cancer patients: evidence for actionable target using patient-derived tumor cell line

22 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5356878

Detection of novel and potentially actionable anaplastic lymphoma kinase (ALK) rearrangement in colorectal adenocarcinoma by immunohistochemistry screening

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5356878

Clinical Response to Sorafenib in a Patient with Metastatic Colorectal Cancer and FLT3 Amplification

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5356878

Dynamics of genomic clones in breast cancer patient xenografts at single-cell resolution.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5356878

Comprehensive molecular profiling of lung adenocarcinoma

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5356878

Comprehensive molecular characterization of gastric adenocarcinoma

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5356878

Crenolanib is a potent inhibitor of FLT3 with activity against resistance-conferring point mutants

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5356878

Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5356878

Comprehensive molecular characterization of human colon and rectal cancer

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5356878

The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5356878

AC220 is a uniquely potent and selective inhibitor of FLT3 for the treatment of acute myeloid leukemia (AML)

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5356878

FMS-like tyrosine kinase 3-internal tandem duplication tyrosine kinase inhibitors display a nonoverlapping profile of resistance mutations in vitro

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5356878

The role of FLT3 in haematopoietic malignancies

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5356878

Finding the next Gleevec: FLT3 targeted kinase inhibitor therapy for acute myeloid leukemia

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5356878

Mechanisms underlying mutational signatures in human cancers

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5356878

The evolving role of FLT3 inhibitors in acute myeloid leukemia: quizartinib and beyond

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5356878

FLT3 inhibitors for acute myeloid leukemia: a review of their efficacy and mechanisms of resistance

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5356878

Clinicopathogenomic analysis of mismatch repair proficient colorectal adenocarcinoma uncovers novel prognostic subgroups with differing patterns of genetic evolution.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5356878

Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5356878

Integrated analysis of cancer-related pathways affected by genetic and epigenetic alterations in gastric cancer.

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5356878

Identification of driver and passenger mutations of FLT3 by high-throughput DNA sequence analysis and functional assessment of candidate alleles

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5356878

Internal tandem duplication of the flt3 gene found in acute myeloid leukemia

1 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27906677

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.18632/ONCOTARGET.13700

1 reference

22 August 2017

1 reference

22 August 2017

PubMed publication ID

27906677

1 reference